Age: 36
Free Agency: 2025 (Void)
Accrued Seasons: 12
- Height: 6'3"
- Weight: 295
- College: Cincinnati
- Entry: 2011 Draft, Round 6, #191 overall (Eagles)
- 2023 Salary Cap Charge: $10,757,000 (4.59% of cap)
- 2023 Cash Payout: $14,500,000 (5.64% of spending)
- 2023 Cash to Cap Ratio: 1.35
- Contract Value: $14,250,000 ($14,250,000 APY)
- Fully Guaranteed Money: $14,250,000
- Contract Ranking: 1/68 at C
Current Contract
(Other, signed 2023)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 36 | $1,165,000 | $9,592,000 | $0 | $1,165,000 | $10,757,000 | 4.6% | |||||
| 2024
June 3: Effective contract void date
| 37 | $1,500,000 | $8,078,000 | $2,750,000 | $2,750,000 | $12,328,000 | 4.7% | |||||
| 2025
February 18: Contract voids
| 38 | Void | $6,678,000 | Void | Void | $14,038,000 | 5.0% | |||||
| 2026 | 39 | Void | $4,693,000 | Void | Void | $0 | 0.0% | |||||
| 2027 | 40 | Void | $2,667,000 | Void | Void | $0 | -- | |||||
| Total | $2,665,000 | $31,708,000 | $2,750,000 | $3,915,000 | $37,123,000 | |||||||
Contract Notes
Jason Kelce signed a one year, $14.25 million contract with the Eagles. The contract is designed to allow the Eagles to carry Kelce on the roster until June of 2024 and place him on the retired list if he wants to retire in 2024. If he does not want to retire the Eagles would be able to sign him to an extension or would need to release him by early June.
Cash Flows
| 2023 | 2024 | |
|---|---|---|
| Cash Due | $11,500,000 | $4,250,000 |
| Running Cash | $10,000,000 | $14,250,000 |
Career Earnings: $81,675,432
Career APY: $6,806,286
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Eagles | Drafted | Renegotiated | 2011 | 4 | $2,137,432 | $534,358 | $97,432 | $1,492,432 | 69.8% | $497,477 |
| Eagles | Extension | Renegotiated | 2014 | 6 | $37,667,000 | $6,277,833 | $10,398,000 | $25,598,000 | 68.0% | $5,119,600 |
| Eagles | Other | Extended | 2019 | 3 | $24,500,000 | $8,166,667 | $10,500,000 | $20,000,000 | 81.6% | $10,000,000 |
| Eagles | Other | Extended | 2021 | 1 | $9,000,000 | $9,000,000 | $9,000,000 | $11,000,000 | 122.2% | $11,000,000 |
| Eagles | Other | Extended | 2022 | 1 | $14,000,000 | $14,000,000 | $14,000,000 | $13,250,000 | 94.6% | $13,250,000 |
| Eagles | Other | Active | 2023 | 1 | $14,250,000 | $14,250,000 | $14,250,000 | $10,335,000 | 72.5% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Eagles | 12 | $81,675,432 | $6,806,286 | $50,567,432 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Other Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | Eagles | $375,000 | $24,358 | $0 | $0 | $0 | $399,358 | 0.3% | $472,432 | ||
| 2012 | Eagles | $465,000 | $24,358 | $0 | $0 | $0 | $489,358 | 0.4% | $465,000 | ||
| 2013 | Eagles | $555,000 | $24,358 | $0 | $0 | $0 | $579,358 | 0.4% | $555,000 | ||
| 2014 | Eagles | $1,398,000 | $1,224,358 | $0 | $0 | $1,398,000 | $2,622,358 | 1.7% | $7,398,000 | ||
| 2015 | Eagles | $3,200,000 | $1,200,000 | $0 | $0 | $3,000,000 | $4,400,000 | 2.8% | $3,200,000 | ||
| 2016 | Eagles | $4,000,000 | $1,200,000 | $0 | $0 | $2,602,000 | $5,200,000 | 3.2% | $4,000,000 | ||
| 2017 | Eagles | $5,000,000 | $1,200,000 | $0 | $0 | $0 | $6,200,000 | 3.5% | $5,000,000 | ||
| 2018 | Eagles | $6,000,000 | $1,200,000 | $0 | $0 | $0 | $7,200,000 | 4.0% | $6,000,000 | ||
| 2019 | Eagles | $930,000 | $1,514,000 | $0 | $0 | $930,000 | $2,444,000 | 1.2% | $8,500,000 | ||
| 2020 | Eagles | $2,000,000 | $2,914,000 | $2,000,000 | $500,000 | $4,000,000 | $7,414,000 | 3.3% | $11,500,000 | ||
| 2021 | Eagles | $1,075,000 | $4,499,000 | $0 | $0 | $1,075,000 | $5,574,000 | 2.7% | $11,000,000 | ||
| 2022 | Eagles | $1,120,000 | $6,925,000 | $0 | $0 | $1,120,000 | $8,045,000 | 3.6% | $13,250,000 | ||
| 2023 | Eagles | $1,165,000 | $9,592,000 | $0 | $0 | $1,165,000 | $10,757,000 | 4.6% | $14,500,000 | ||
| 2024 | Eagles | $1,500,000 | $8,078,000 | $2,750,000 | $0 | $2,750,000 | $12,328,000 | 4.7% | $4,250,000 | ||
| 2025 | Eagles | $0 | $6,678,000 | $0 | $0 | $0 | $14,038,000 | 5.0% | $0 | ||
| 2026 | Eagles | $0 | $4,693,000 | $0 | $0 | $0 | $0 | 0.0% | $0 | ||
| 2027 | Eagles | $0 | $2,667,000 | $0 | $0 | $0 | $0 | -- | $0 | ||
| Total | $28,783,000 | $53,657,432 | $4,750,000 | $500,000 | $18,040,000 | $87,690,432 | $90,090,432 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | ||
|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | ||
| 2011 | -- | -- | 99.4% | 0.0% | |
| 2012 | 2 | -- | -- | 12.1% | 1.1% |
| 2013 | 16 | 0 | 0 | 99.3% | 0.0% |
| 2014 | 12 | 4 | 0 | 70.3% | 1.2% |
| 2015 | 16 | 0 | 0 | 100.0% | 0.0% |
| 2016 | 16 | 0 | 0 | 100.0% | 1.8% |
| 2017 | 16 | 0 | 0 | 95.4% | 0.0% |
| 2018 | 16 | 0 | 0 | 95.0% | 0.0% |
| 2019 | 16 | 0 | 0 | 100.0% | 0.2% |
| 2020 | 16 | 0 | 0 | 99.6% | 0.0% |
| 2021 | 17 | 0 | 0 | 88.7% | 0.0% |
| 2022 | 17 | 0 | 0 | 97.6% | 0.0% |
| 2023 | 2 | 0 | 0 | 100.0% | 0.0% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $10,816,000 | $14,250,000 |
| Injury Adjusted | $10,816,000 | $14,250,000 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.